Fluticasone propionate and Salmeterol
Active substance: FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE
POWDER · FLUTICASONE PROPIONATE 250 ug/1, SALMETEROL XINAFOATE 50 ug/1
United StatesActive
Marketing holder: Cipla USA Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- FLUTICASONE PROPIONATE · 250 ug/1
- SALMETEROL XINAFOATE · 50 ug/1
Products containing fluticasone propionate in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| EU 4 |
|
Registration
- Registration number
- 69097-661
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- RESPIRATORY (INHALATION)
Sources
- product · openFDA NDC · 69097-661 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 69097-661 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 69097-661 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 69097-661 · Verified 2026-10-09 · open in source